NET Cancer Blogger and Advocate Winner in WEGO Health Activist Awards — Best in Show Community

December 6, 2016

Congratulations to Ronny Allan, @NETCancerBlog, upon winning the 2016 WEGO Health Activist Award for Best in Show Community.  He was also a finalist in the Best in Show Blog category. The winners of the WEGO Health Activist Awards were announced on during…

READ MORE

Call for Nominations: 7th Annual Warner Advocacy Award

November 11, 2016

Novartis Oncology and The NET Alliance have announced that nominations are open for the 7th Annual Warner Advocacy Award. This annual award was established by Novartis in 2009 in honor of Monica Warner, who passed away in August 2009, to recognize the …

READ MORE

Join Our #14DaysOfGratitude

November 11, 2016

Check out our video Fighting NET Cancer with Grace & Gratitude and tell us about your appreciation for the things that matter most to you in the 14 days between NET Cancer Day and Thanksgiving.  Tell us about your friends, family, support group members,…

READ MORE

Project Zebra Report: Real-World Insights from the Carcinoid and NET Patient Community

November 10, 2016

In honor of Worldwide NET Cancer Awareness Day, we are pleased to release the first ever Project Zebra Report: Real-World Insights from the Carcinoid and Neuroendocrine Tumor Patient Community, a collaboration between our partner Self Care Catalysts

READ MORE

Carcinoid/Neuroendocrine Cancer Specialist Announces Retirement from Medical Practice

October 15, 2016

Dr. Richard R.P. Warner, Director of the Center for Carcinoid and Neuroendocrine Tumors at Mount Sinai Hospital, has announced that he is retiring from his medical practice at Mount Sinai, as of November 1, 2016. Read more

READ MORE

Stanford Health Care in California Launches Neuroendocrine Tumor Multidisciplinary Program

August 14, 2016

A new multidisciplinary Neuroendocrine Cancer center at Stanford Health Care in California has been established to improve the standard of care for NET patients and to advance the study of these rare diseases. Pamela Kunz, MD, is the Medical Director…

READ MORE

Carcinoid Cancer Foundation Announces Appointment of Edward M. Wolin, MD as Co-Medical Director and Board Member

June 24, 2016

Edward M. Wolin, MD, an internationally renowned neuroendocrine cancer specialist and medical oncologist, has been named Co-Medical Director and Board member of the Carcinoid Cancer Foundation (CCF) in White Plains, New York.  Dr. Wolin is Director

READ MORE

FDA Priority Review of Lexicon’s New Drug Application for Telotristat Etiprate Treatment for Carcinoid Syndrome

May 31, 2016

Lexicon Pharmaceuticals announced on May 31, 2016 that the U.S. Food and Drug Administration has accepted for filing the New Drug Application for telotristat etiprate, an oral drug for the treatment of CARCINOID SYNDROME. “The FDA has granted…

READ MORE

Ipsen Partners with CCF and Self Care Catalysts to Provide Free Support App for Neuroendocrine Tumor Patients

April 6, 2016

Ipsen Biopharmaceuticals has partnered with the Carcinoid Cancer Foundation and Self Care Catalysts to provide a digital patient support tool known as the Carcinoid NETs Health Storylines mobile and web application. Sponsored in part by Ipsen, the…

READ MORE

Lexicon Pharmaceuticals Submits New Drug Application for Telotristat Etiprate

April 3, 2016

Lexicon Pharmaceuticals has submitted a new drug application to the US Food and Drug Administration (FDA) for Telotristat Etiprate for the treatment of carcinoid syndrome.

For patients with carcinoid syndrome who are no longer responding to the current…

READ MORE